HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bour, S. Articles by Strebel, K. Search for Related Content PubMed PubMed Citation Articles by Bour, S. Articles by Strebel, K. Social Bookmarking                      What's this?

J Biol Chem, Vol. 274, Issue 47, 33800-33806, November 19, 1999

Cell Surface CD4 Inhibits HIV-1 Particle Release by Interfering with Vpu Activity

From the Laboratory of Molecular Microbiology, NIAID, National Institutes of Health, Bethesda, Maryland 20892-0460

One of the hallmarks of human immunodeficiency virus type I (HIV-1) infection is the rapid removal of the viral receptor CD4 from the cell surface. This remarkably efficient receptor interference requires the activity of three separate viral proteins: Env, Vpu, and Nef. We have investigated whether this unusually tight interference on cell surface CD4 expression had a more essential function during the viral life cycle than simply preventing superinfection. We now report that the removal of cell surface CD4 is required for optimal virus production by HIV-1. Indeed, maintenance of CD4 surface expression in infected cells lead to a 3-5-fold decrease in viral particle production. This effect was not due to the formation of intracellular complexes between CD4 and the gp160 viral envelope precursor but instead required the presence of CD4 at the cell surface and was specifically mediated by CD4 but not closely related plasma membrane receptors. The finding that CD4 had no significant effect on particle release by a Vpu-deficient variant indicates that CD4 acts by inhibiting the particle release-promoting activity of Vpu. Co-immunoprecipitation experiments further showed that CD4 and Vpu physically interact at the cell surface, suggesting that CD4 might inhibit Vpu activity by disrupting its oligomeric structure.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				N. Laguette, C. Bregnard, J. Bouchet, A. Benmerah, S. Benichou, and S. Basmaciogullari Nef-Induced CD4 Endocytosis in Human Immunodeficiency Virus Type 1 Host Cells: Role of p56lck Kinase J. Virol., July 15, 2009; 83(14): 7117 - 7128. [Abstract] [Full Text] [PDF]

				E. Miyagi, A. J. Andrew, S. Kao, and K. Strebel Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion PNAS, February 24, 2009; 106(8): 2868 - 2873. [Abstract] [Full Text] [PDF]

				B. Poon, M. A. Chang, and I. S. Y. Chen Vpr Is Required for Efficient Nef Expression from Unintegrated Human Immunodeficiency Virus Type 1 DNA J. Virol., October 1, 2007; 81(19): 10515 - 10523. [Abstract] [Full Text] [PDF]

				S. Wildum, M. Schindler, J. Munch, and F. Kirchhoff Contribution of vpu, env, and nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J. Virol., August 1, 2006; 80(16): 8047 - 8059. [Abstract] [Full Text] [PDF]

				W.-E. Chan, H.-H. Lin, and S. S.-L. Chen Wild-Type-Like Viral Replication Potential of Human Immunodeficiency Virus Type 1 Envelope Mutants Lacking Palmitoylation Signals J. Virol., July 1, 2005; 79(13): 8374 - 8387. [Abstract] [Full Text] [PDF]

				H. M. Pham, E. R. Arganaraz, B. Groschel, D. Trono, and J. Lama Lentiviral Vectors Interfering with Virus-Induced CD4 Down-Modulation Potently Block Human Immunodeficiency Virus Type 1 Replication in Primary Lymphocytes J. Virol., December 1, 2004; 78(23): 13072 - 13081. [Abstract] [Full Text] [PDF]

				E. R. Arganaraz, M. Schindler, F. Kirchhoff, M. J. Cortes, and J. Lama Enhanced CD4 Down-modulation by Late Stage HIV-1 nef Alleles Is Associated with Increased Env Incorporation and Viral Replication J. Biol. Chem., September 5, 2003; 278(36): 33912 - 33919. [Abstract] [Full Text] [PDF]

				K. Levesque, Y.-S. Zhao, and E. A. Cohen Vpu Exerts a Positive Effect on HIV-1 Infectivity by Down-modulating CD4 Receptor Molecules at the Surface of HIV-1-producing Cells J. Biol. Chem., July 18, 2003; 278(30): 28346 - 28353. [Abstract] [Full Text] [PDF]

				H. Akari, S. Bour, S. Kao, A. Adachi, and K. Strebel The Human Immunodeficiency Virus Type 1 Accessory Protein Vpu Induces Apoptosis by Suppressing the Nuclear Factor {kappa}B-dependent Expression of Antiapoptotic Factors J. Exp. Med., November 5, 2001; 194(9): 1299 - 1312. [Abstract] [Full Text] [PDF]

				E. Schaeffer, R. Geleziunas, and W. C. Greene Human Immunodeficiency Virus Type 1 Nef Functions at the Level of Virus Entry by Enhancing Cytoplasmic Delivery of Virions J. Virol., March 15, 2001; 75(6): 2993 - 3000. [Abstract] [Full Text]

				S. Bour, C. Perrin, H. Akari, and K. Strebel The Human Immunodeficiency Virus Type 1 Vpu Protein Inhibits NF-kappa B Activation by Interfering with beta TrCP-mediated Degradation of Ikappa B J. Biol. Chem., May 4, 2001; 276(19): 15920 - 15928. [Abstract] [Full Text] [PDF]

				M. J. Cortes, F. Wong-Staal, and J. Lama Cell Surface CD4 Interferes with the Infectivity of HIV-1 Particles Released from T Cells J. Biol. Chem., January 11, 2002; 277(3): 1770 - 1779. [Abstract] [Full Text] [PDF]